Our targeted metabolomic analysis indicates the intracellular increase of arginine induced by cisplatin treatment is exhausted by pharmacological inhibition of TRPML1 in ovarian cancer cell line and patient-derived cancer cells. Here, MCOLN1 is linked to ovarian cancer.